BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 524230)

  • 1. [Advances in the epidemiology of infection in the granulocytopenic patient (author's transl)].
    Garau Alemany J
    Sangre (Barc); 1979; 24(5B):836-44. PubMed ID: 524230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylaxis of infections in granulocytopenic patients (author's transl].
    Grañena A; Rozman C; Aranalde JM; Feliú E; García J; Marín P; Montserrat-Costa E; Ribas Mundo M; Matutes E
    Sangre (Barc); 1979; 24(5B):857-67. PubMed ID: 524232
    [No Abstract]   [Full Text] [Related]  

  • 3. [Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient (author's transl)].
    Vivancos Pujol MP; Alemany A; Clavo M; Rubio Baget A; Sans Botargues R; Ferran C
    Sangre (Barc); 1979; 24(5B):896-903. PubMed ID: 524234
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effectiveness of granulocyte transfusions in the treatment of severe injections in granulocytopenic patients. A controlled trial (author's transl)].
    Grañena A; Aranalde JM; Feliu E; Muncunill J; Montserrat E; Hernandez Nieto L; Rozman C
    Sangre (Barc); 1978; 23(3):291-7. PubMed ID: 675453
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis in severe granulocytopenia.
    Thompson EI; Callihan TR; Mauer AM
    Adv Intern Med; 1984; 29():193-214. PubMed ID: 6369925
    [No Abstract]   [Full Text] [Related]  

  • 6. [Considerations on the use of granulocytes obtained by intermittent flow centrifugation [IFC] in the transfusion to granulocytopenic patients (author's transl)].
    Fernández MN; Barbolla L; Sanjuan I; Cabrera R; Regidor MC; Pérez Alvarez L; Zabala P
    Sangre (Barc); 1979; 24(5B):878-95. PubMed ID: 524233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute drug-induced agranulocytosis: comparison between openward treatment and antimicrobial decontamination in a plastic isolation bed system (retrospective study of 30 cases) (author's transl)].
    Abt C; Dietrich M; Niethammer D; Arnold R; Pflieger H; Töllner U; Vanek E; Kubanek B; Kleihauer E; Heimpel H
    Dtsch Med Wochenschr; 1978 Jan; 103(3):108-14. PubMed ID: 624249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte transfusions in leukopenic dogs.
    Epstein RB; Zander AR
    Prog Clin Biol Res; 1977; 13():227-41. PubMed ID: 859889
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 10. Fever in the patient with cancer. Pathophysiology and the initial evaluation and management.
    Gutiérrez-Nuñez JJ
    Bol Asoc Med P R; 1984 Jun; 76(6):256-64. PubMed ID: 6380516
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusions.
    Buckner CD; Clift RA
    Clin Haematol; 1984 Oct; 13(3):557-72. PubMed ID: 6388932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
    Gaya H
    Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood cultures-bacteriological and drug resistance culture (author's transl)].
    Moreno G; Granado C; Lopes CA; de Campos CE
    Arq Inst Biol (Sao Paulo); 1975; 42():233-8. PubMed ID: 1236053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
    Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
    J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
    [No Abstract]   [Full Text] [Related]  

  • 15. Perils of prophylaxis.
    Jacoby GA
    N Engl J Med; 1982 Jan; 306(1):43-4. PubMed ID: 7053471
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte transfusion therapy.
    Dutcher JP
    Am J Med Sci; 1984; 287(2):11-7. PubMed ID: 6711583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Granulocyte transfusion (author's transl)].
    Zapata C
    Rev Med Chil; 1980 Dec; 108(12):1132-42. PubMed ID: 7029692
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.
    Gaya H
    Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of multidiscs for determination of polyresistance of microorganisms to antibiotics (author's transl)].
    Antal M; Paulíková B; Janousková J; Krcméry V; Stĕpánková E; Baláziková M
    Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):129-35. PubMed ID: 126810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.